Future Perspectives in EGFR-Mutant Advanced NSCLC
Panelists discuss novel agents and strategies being explored for the future treatment of advanced EGFR-mutant NSCLC, sharing optimism about emerging therapies that could significantly improve patient outcomes.
EP: 1.Overview of EGFR-Mutant Advanced NSCLC
EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians
EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach
EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective
EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC
EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey
EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC
EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC
EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective
EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab
EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC
EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey
Now Viewing
EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC
Video content above is prompted by the following:
- Dr. Spira: At a high level, what novel agents and strategies are being explored that you are hopeful for in the future treatment of advanced EGFR-Mutant NSCLC?
Recent Videos
